Graves SA - Search Results

1

Reply: Single-Time-Point Tumor Dosimetry Assuming Normal Distribution of Tumor Kinetics.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: graves sa. J Nucl Med. 2022 May;63(5):804. doi: 10.2967/jnumed.121.263717. Epub 2022 Mar 10. J Nucl Med. 2022. PMID: 35273095 Free article. No abstract available.

2

Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns.

Sgouros G, Dewaraja YK, Escorcia F, Graves SA, Hope TA, Iravani A, Pandit-Taskar N, Saboury B, James SS, Zanzonico PB. Sgouros G, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):12S-22S. doi: 10.2967/jnumed.121.262750. J Nucl Med. 2021. PMID: 34857617 Free article. Review.

3

Normal-Tissue Tolerance to Radiopharmaceutical Therapies, the Knowns and the Unknowns.

Wahl RL, Sgouros G, Iravani A, Jacene H, Pryma D, Saboury B, Capala J, Graves SA. Wahl RL, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):23S-35S. doi: 10.2967/jnumed.121.262751. J Nucl Med. 2021. PMID: 34857619 Free article. No abstract available.

4

Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources.

Capala J, Graves SA, Scott A, Sgouros G, James SS, Zanzonico P, Zimmerman BE. Capala J, et al. Among authors: graves sa. J Nucl Med. 2021 Dec;62(Suppl 3):3S-11S. doi: 10.2967/jnumed.121.262749. J Nucl Med. 2021. PMID: 34857621 Free article. Review.

5

Dosimetry for Optimized, Personalized Radiopharmaceutical Therapy.

Graves SA, Hobbs RF. Graves SA, et al. Semin Radiat Oncol. 2021 Jan;31(1):37-44. doi: 10.1016/j.semradonc.2020.07.008. Semin Radiat Oncol. 2021. PMID: 33246635 Review.

6

Impact of radiopharmaceutical therapy (¹⁷⁷Lu, ²²⁵Ac) microdistribution in a cancer-associated fibroblasts model.

Tranel J, Palm S, Graves SA, Feng FY, Hope TA. Tranel J, et al. Among authors: graves sa. EJNMMI Phys. 2022 Sep 30;9(1):67. doi: 10.1186/s40658-022-00497-5. EJNMMI Phys. 2022. PMID: 36178531 Free PMC article.

7

Reimbursement Approaches for Radiopharmaceutical Dosimetry: Current Status and Future Opportunities.

Graves SA, Bageac A, Crowley JR, Merlino DAM. Graves SA, et al. J Nucl Med. 2021 Dec;62(Suppl 3):48S-59S. doi: 10.2967/jnumed.121.262752. J Nucl Med. 2021. PMID: 34857622 Free article.

8

Basics of Physics and Radiobiology for Radiopharmaceutical Therapies.

English KK, Knox S, Graves SA, Kiess AP. English KK, et al. Among authors: graves sa. Pract Radiat Oncol. 2022 Jul-Aug;12(4):289-293. doi: 10.1016/j.prro.2022.04.004. Pract Radiat Oncol. 2022. PMID: 35717042 No abstract available.

9

PET Imaging of VEGFR-2 Expression in Lung Cancer with 64Cu-Labeled Ramucirumab.

Luo H, England CG, Graves SA, Sun H, Liu G, Nickles RJ, Cai W. Luo H, et al. Among authors: graves sa. J Nucl Med. 2016 Feb;57(2):285-90. doi: 10.2967/jnumed.115.166462. Epub 2015 Nov 5. J Nucl Med. 2016. PMID: 26541778 Free PMC article.

10

Preclinical Pharmacokinetics and Biodistribution Studies of 89Zr-Labeled Pembrolizumab.

England CG, Ehlerding EB, Hernandez R, Rekoske BT, Graves SA, Sun H, Liu G, McNeel DG, Barnhart TE, Cai W. England CG, et al. Among authors: graves sa. J Nucl Med. 2017 Jan;58(1):162-168. doi: 10.2967/jnumed.116.177857. Epub 2016 Aug 4. J Nucl Med. 2017. PMID: 27493273 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters